Skip to content

Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium

Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium Under Routine Clinical Practice

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02785653
Acronym
SRI
Enrollment
60
Registered
2016-05-30
Start date
2004-04-30
Completion date
2006-11-30
Last updated
2016-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Relaxation Caused by Sevoflurane

Keywords

sevoflurane, rocuronium, intubation

Brief summary

This study evaluates the potentiation of muscle relaxation caused by rocuronium by inhalational agent sevoflurane. Half the patients will be ventilated with oxygen ,nitrous oxide and sevoflurane during induction of anaesthesia and half will be ventilated only with oxygen and nitrous oxide.

Detailed description

Rocuronium is a non depolarizing muscle relaxant. Inhalational general anaesthetic agents like Sevoflurane have some muscle relaxation effect by depressing the spinal motor neurons. Inhalational anaesthetics also alter the tonic input received from descending modulatory systems from the brain. Deep anaesthesia with inhalational agents may cause some degree of neuromuscular blockade.

Interventions

DRUGSevoflurane

Patients were ventilated with 2 % inspired concentration of sevoflurane in a fresh gas flow of 5 litres containing 66.6% nitrous oxide and 33.3% percent of oxygen

DRUGRocuronium

rocuronium 0.6mg per kg body weight was given intravenously after induction of anaesthesia

Sponsors

Jaslok Hospital and Research Centre
CollaboratorOTHER
Maharashtra University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American society of anaesthesiologists physical status 1 and 2 * Age between 18-65 * Mallampatti classification 1 and 2

Exclusion criteria

* Patients refusal to participate * American society of anaesthesiologists physical status 3 and 4 * Mallampatti classification 3 and 4 * Patients with neuromuscular disorder * Patients on medications that affect neuromuscular block * Pregnant and lactating patients

Design outcomes

Primary

MeasureTime frameDescription
intubating condition10 minutesCopenhagen Consensus Conference Scale-scale to assess ease of intubation consisting of 5 parameters.laryngoscopy,vocal cord movement,vocal cord position,movement at intubation,coughing at intubation all are judged as poor ,good or excellent.If any parameter has a poor score, it is a clinically unacceptable intubating condition.

Secondary

MeasureTime frameDescription
lag time10 minutestime from start of rocuronium injection to first change in single twitch height on neuromuscular monitor
onset time for maximum relaxation10 minutestime from start of rocuronium injection to the disappearance of all four twitches on train of four stimulus on neuromuscular monitor

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026